#oncology — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #oncology, aggregated by home.social.
-
Cancer care is changing.
Precision medicine, immunotherapy, AI and earlier detection are reshaping oncology.
Explore the future of cancer research: https://www.newsletter.co.uk/your-world/cancer-at-a-turning-point-how-science-is-changing-the-fight-against-the-disease-9055435
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
www.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
Hey, I'm Birk, Co-founder of #CYMANTICMEDICAL an #Irish #Medtech #startup addressing the issue of inadequate sampling during #cancer #biopsies.
We are taking part in the #medtechinnovator #accelerator in #sanfrancisco the world's biggest medtech accelerator. Part of it is a video competition and our video is now online and we need YOU to WATCH, VOTE and SHARE!
About 25% of cancer biopsies are inadequate for a diagnosis and 30% of cancer surgeries are incomplete - meaning they require a repeat procedure weeks after the first.
This takes a toll on the patients, delays diagnosis and treatment and drives up the cost by 40% to 80% and reducing the hospital throughput while the timing for the patients would be critical.
We address this via automated sample preparation and computer vision to get real time results directly in the procedure room.
Please , watch our video, vote and share:
https://medtechinnovator.org/company-videos-2026/?record=65702
#cancer #surgery #biopsy #startup #Dublin #medtechinnovator #MTI #BRYCK #UCD #neurodivergent #oncology 🖖🤓🤘
#computervisionwww.cymanticmedical.com
-
New prostate cancer screening advances improve early detection
Did you know that about 1 in 8 men will be diagnosed with prostate cancer during their lifetime?…
#NewsBeep #News #Health #Biopsy #Blood #cancer #Doctor #GB #Oncology #primarycare #Prostate #Prostatecancer #surgery #UK #UnitedKingdom
https://www.newsbeep.com/uk/762946/ -
https://www.europesays.com/ie/675705/ New prostate cancer screening advances improve early detection #biopsy #blood #cancer #doctor #Éire #Health #IE #Ireland #oncology #PrimaryCare #Prostate #ProstateCancer #Surgery
-
Medidata Expands Partnership with The Menarini Group,
NEW YORK, March 09, 2026 (GLOBE NEWSWIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical…
#France #FR #Europe #EU #DassaultSystèmes #clinicaldevelopment #clinicalstudies #ClinicalTrials #Dassault #Inc. #Medidata #MedidataSolutions #Menarini #Oncology #ParisStockExchange:DSY.PA
https://www.europesays.com/france/28461/ -
Medidata’s Next-Gen AI Imaging Solution Delivers
NEW YORK, May 28, 2026 (GLOBE NEWSWIRE) — Medidata, a Dassault Systèmes brand and leading provider of clinical…
#France #FR #Europe #EU #DassaultSystèmes #ai #ASCO #ClinicalData #clinicalstudies #ClinicalTrials #Dassault #Imaging #Inc. #LifeSciences #Medidata #MedidataSolutions #Oncology #ParisStockExchange:DSY.PA
https://www.europesays.com/france/26316/